Half of U.S. economic growth since WWII stems from innovation made possible by federally-funded research. More recently, federally funded studies by the National Institutes of Health (NIH) contributed to the science that underlies every one of the 210 new drugs approved between 2010 and 2016.
Yet, today, the United States is rapidly losing its competitive advantage in biomedical engineering & innovation. The U.S. now ranks 4th on the Global Innovation Index, down from 1st in 2007.
Federal budget cuts have allowed the purchasing power of the National Institute of Health (NIH) to dip 20% in the past decade — resulting in a decline of the funding of qualified NIH research proposals from 30.5% to just 19.1%.
Nearly 20% of U.S. academic researchers are considering conducting research overseas due to lack of funding prospects.
Now is a critical time for researchers to get engaged and educate lawmakers about why medical and biological innovation is mission-critical to the health, well-being, and prosperity of the U.S.
Show your support for medical and biological engineering. Advocate for long-term, consistent funding for our nation’s science agencies. Raise your voice for science today!
Investments in NIH support the work of researchers across the country whose discoveries and innovations save lives and improve the health and well-being of Americans. Share this important message with your Members of Congress about how NIH is an engine for both medical and economic progress. Download, print, and distribute this 1-pager to Congressional staff during your Capitol Hill visits.
AIMBE Flash is the fastest way to catch up with today’s news at the intersection of public policy and biomedical innovation. Each issue tells you what you need to know this week, which issues are emerging, and an interesting development. Additionally, AIMBE Flash has a curated selection of AIMBE Fellowbook News, the best place to see what the leaders of medical and biological engineering are accomplishing today. AIMBE Flash ends with the “Big Number”–a surprising statistic that is indicative of our changing world.
When you join AIMBE in Standing Up for Science, we’ll keep you informed about the public policies shaping the medical and biological engineering community. We monitor and analyze policy developments and participate in coalitions to add our voice to public policy decisions.
Among AIMBE’s most important roles is the promotion of public policies that foster continued advancement in medical and biological engineering (MBE). We educate public officials, regulators, the media and general public about the positive impact MBE has on virtually every sector of society. AIMBE advocates for public policy solutions that assistant our community at each stage of the innovation ecosystem–from the research lab to the bedside of a patient.